BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33129843)

  • 1. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
    Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
    Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
    Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
    Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ; Ryu SJ; Lim HW; Lee BR
    Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy.
    Kim KE; Kim JH; Kim YH; Ahn SJ
    Sci Rep; 2022 Jul; 12(1):11809. PubMed ID: 35821509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
    Pham BH; Marmor MF
    Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thicknesses in Hydroxychloroquine Retinopathy.
    Kim KE; Kim YH; Kim J; Ahn SJ
    Am J Ophthalmol; 2023 Jan; 245():70-80. PubMed ID: 35963445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
    Melles RB; Marmor MF
    Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
    Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
    Ahn SJ; Joung J; Lim HW; Lee BR
    Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
    Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
    Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.
    Turgut B; Turkcuoglu P; Serdar Koca S; Aydemir O
    Clin Rheumatol; 2009 May; 28(5):607-9. PubMed ID: 19221829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual field examinations using different strategies in Asian patients taking hydroxychloroquine.
    Kim KE; Ryu SJ; Kim YH; Seo Y; Ahn SJ
    Sci Rep; 2022 Aug; 12(1):14778. PubMed ID: 36042337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of photoreceptor outer segment length in hydroxychloroquine users.
    Cakir A; Ozturan ŞG; Yildiz D; Erden B; Bolukbasi S; Tascilar EK; Yanmaz MN; Elcioglu MN
    Eye (Lond); 2019 Aug; 33(8):1321-1326. PubMed ID: 30932033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.